Quick answer: GERD (gastroesophageal reflux disease) is not caused by too much stomach acid in most patients — it is caused by low stomach acid, H. pylori infection, hiatal hernia, SIBO, dietary triggers, and impaired lower esophageal sphincter function. Proton pump inhibitors provide symptomatic relief while worsening the underlying root causes.
Proton pump inhibitors (PPIs) are the third most prescribed medication class in the world, yet approximately 40% of PPI users have functional dyspepsia or conditions that PPIs cannot address — while creating new problems. The functional medicine approach to GERD involves identifying whether the patient has hypochlorhydria (the most commonly missed cause), H. pylori, SIBO, hiatal hernia, esophageal dysmotility, or dietary/lifestyle drivers — and addressing each specifically rather than suppressing all gastric acid production.
The Hypochlorhydria Paradox: Low Acid Causes GERD
Paradoxically, low stomach acid (hypochlorhydria) is a primary driver of GERD and is far more common than hyperchlorhydria (excess acid). The mechanism: adequate gastric acid (pH 1–3) is required to properly signal the lower esophageal sphincter (LES) to close after food passage. When stomach acid is insufficient, the pyloric valve fails to close properly, allowing food to ferment and produce gases that create pressure pushing contents — even low-pH gastric contents — upward into the esophagus. Jonathan Wright, MD pioneered this clinical observation in his thousands of patients: HCL supplementation resolved GERD in the majority who tested positive for hypochlorhydria via Heidelberg pH testing.
Causes of hypochlorhydria: H. pylori infection (suppresses parietal cell HCL secretion via urease-mediated ammonia), aging (gastric acid secretion declines 40% from age 30 to 80), zinc deficiency (zinc is required for carbonic anhydrase in parietal cells — the enzyme producing HCL), chronic stress (vagal tone impairment reduces cephalic acid secretion), PPI use (creates the dependency cycle), and autoimmune gastric atrophy (anti-parietal cell antibodies). The HCL challenge test: take 1 capsule of betaine HCL with protein meal — if warmth/burning sensation, acid is adequate; if no sensation, likely hypochlorhydric. Formal testing: Heidelberg pH capsule or Bravo pH monitoring.
H. pylori: The Hidden GERD and Gastric Disease Driver
Helicobacter pylori infects 44% of the global population and is the primary cause of peptic ulcer disease, gastric cancer (the third leading cancer cause of death globally), and a major contributor to GERD, gastritis, and hypochlorhydria. H. pylori produces urease → ammonia → neutralizes gastric acid → disrupts mucosal integrity → creates a feedback loop of impaired digestion and reflux. Critically, H. pylori-negative patients with GERD have a fundamentally different condition requiring different treatment than H. pylori-positive patients.
Testing: H. pylori urea breath test (gold standard for active infection), stool antigen test (HpSA, 94% sensitivity), or GI-MAP stool PCR testing (most comprehensive, also identifies virulence factors). Standard eradication: triple therapy (clarithromycin + amoxicillin + PPI ×14 days) has declining efficacy due to clarithromycin resistance (>20% resistance in US); bismuth quadruple therapy (bismuth + metronidazole + tetracycline + PPI) achieves >90% eradication. Functional adjuncts that improve eradication: probiotics (Lactobacillus reuteri DSM 17938 reduces H. pylori density and improves antibiotic tolerance — Emara 2014), mastic gum (Pistacia lentiscus) has bactericidal activity against H. pylori (Bebb 2003, Phytomedicine), and Broccoli sprouts (sulforaphane) — Haristoy 2003 and Yanaka 2009 Clinical Cancer Research showed 40g/day broccoli sprouts for 8 weeks reduced H. pylori density and gastric inflammatory markers in infected patients.
SIBO and Upper GI Symptoms: The Fermentation Connection
Small intestinal bacterial overgrowth (SIBO) — bacteria colonizing the proximal small intestine where they don’t belong — produces fermentation gases (hydrogen, methane, hydrogen sulfide) immediately after eating, increasing intra-abdominal pressure and driving the incompetent LES mechanism. Pimentel et al. (2006, Digestive Diseases and Sciences) demonstrated that SIBO treatment with antibiotics significantly improved GERD symptoms — in some patients producing complete resolution. The overlap between SIBO and GERD is substantial: chronic PPI use itself reduces gastric acid as a barrier, allowing bacterial overgrowth and creating the self-perpetuating PPI-SIBO-GERD cycle.
Methane-producing organisms (Methanobrevibacter smithii) are particularly implicated in slow motility and constipation-predominant SIBO, which increases intraabdominal pressure and GERD risk. Hydrogen SIBO and hydrogen sulfide SIBO produce different symptom profiles. Lactulose breath test (3-hour, measuring both hydrogen and methane) is the standard SIBO diagnostic tool. Treatment: rifaximin 550 mg three times daily for 14 days (elemental diet for 2 weeks has equivalent efficacy, with 80–85% remission per Pimentel 2004). Biofilm disruption agents (NAC, allicin, berberine) are used in refractory or complex SIBO cases.
Hiatal Hernia: Structural Assessment and Conservative Management
Hiatal hernias — protrusion of the stomach through the diaphragmatic hiatus — are present in 60% of people over 60 and are strongly associated with GERD. However, many patients with hiatal hernias don’t have symptomatic GERD, and many GERD patients don’t have hiatal hernias, indicating that the hernia creates vulnerability that other drivers actualize. Hiatal hernia increases GERD by: (1) displacing the LES above the diaphragm, losing the diaphragmatic valve function; (2) impairing esophageal acid clearance; (3) creating an acid pocket just below the LES that is accessible during swallowing-associated LES relaxation.
Conservative hiatal hernia management: specific manual physical therapy techniques (Cuthbert & Goodheart Applied Kinesiology diaphragm pull-down, Lam et al. 2019 systematic review found physiotherapy techniques modestly effective), diaphragmatic breathing exercises strengthen the crura surrounding the hiatus, and positional strategies (left lateral decubent sleep position reduces nocturnal acid reflux 50–87% vs. right lateral position per Khoury 1999, American Journal of Gastroenterology). Avoiding large meals, not lying down within 3 hours of eating, and weight loss (especially central adiposity reduction) are standard structural interventions.
PPI Side Effects: The Hidden Harms
Long-term PPI use carries substantial risks that are rarely discussed with patients at prescription: magnesium deficiency (FDA Black Box Warning 2011 — PPIs interfere with intestinal magnesium transport; Lam et al. 2013, American Journal of Gastroenterology, 2.6% of long-term PPI users develop hypomagnesemia requiring hospitalization), vitamin B12 deficiency (Lam 2013 — long-term PPI use associated with 65% higher risk of B12 deficiency through impaired pepsin-mediated B12-protein cleavage), calcium malabsorption and osteoporosis (PPIs increase hip fracture risk 44% per Gray 2010 JAMA), increased Clostridioides difficile infection risk (2.15× higher per Kwok 2012 American Journal of Gastroenterology), small intestinal bacterial overgrowth development, and rebound hypersecretion upon discontinuation.
PPI-associated dementia: Gomm et al. (2016, JAMA Neurology) — large prospective German cohort (73,679 patients ≥75 years) — found regular PPI use associated with 44% increased risk of dementia. Possible mechanisms: PPIs cross the BBB and may inhibit β/γ-secretase enzymes that clear amyloid-β. Haenisch et al. (2015, European Archives of Psychiatry and Clinical Neuroscience) confirmed PPI-dementia association. PPIs should be used for the shortest effective duration and only when truly indicated — not for functional dyspepsia or non-erosive reflux disease without confirmed esophagitis.
Natural LES Support and Digestive Rehabilitation
Melatonin has surprising efficacy for GERD — the GI tract contains 400× more melatonin than the pineal gland, and esophageal melatonin receptors regulate LES tone and mucosal repair. Pereira et al. (2006, Journal of Pineal Research) randomized 351 GERD patients to melatonin 6mg (alone or combined with conventional therapy) vs. omeprazole: melatonin group improved symptom scores equivalent to omeprazole at 8 weeks — a remarkable finding given melatonin’s excellent safety profile. Dosing for GERD: melatonin 3–6 mg at bedtime (not just for sleep but specifically for esophageal function).
Deglycyrrhizinated licorice (DGL) — licorice with the blood-pressure-elevating glycyrrhizin removed — stimulates mucus secretion, enhances mucosal protective factors, and supports esophageal and gastric healing. Bennett et al. (1980, Lancet) classic trial: DGL 380mg three times daily resolved peptic ulcers comparably to antacids and ranitidine. Aloe vera inner gel (polysaccharides and glycoproteins) reduced GERD symptoms (heartburn, regurgitation, dysphagia) significantly in a blinded RCT (Panahi 2015, Journal of Traditional Chinese Medicine). Slippery elm bark and marshmallow root coat and soothe the esophageal mucosa through mucilaginous polysaccharide action — standard Ayurvedic and naturopathic first-line therapies.
Lifestyle modification with the strongest GERD evidence: weight loss (each BMI unit increase raises esophageal acid exposure 8% — Kjellin 1996), Mediterranean diet adherence (Zalvan 2017, JAMA Otolaryngology — Head & Neck Surgery showed plant-based Mediterranean diet produced GERD symptom reduction comparable to PPI therapy, with superior long-term outcomes), eating smaller meals (reduces gastric distension-driven LES relaxation), elimination of GERD dietary triggers (coffee, alcohol, chocolate, mint, tomatoes, citrus, carbonated beverages, fatty foods), and eating nothing after 7 PM (or at least 3 hours before bed).
Functional GERD Testing Protocol
Comprehensive functional GERD panel: H. pylori urea breath test or GI-MAP stool PCR (includes H. pylori virulence factors), lactulose breath test for SIBO (3-hour hydrogen + methane), serum zinc (zinc deficiency impairs HCL production), serum B12 and RBC folate (impaired if long-term PPI user), RBC magnesium (PPIs deplete magnesium), comprehensive thyroid panel (hypothyroidism slows gastric emptying and causes reflux), fasting insulin and HOMA-IR (insulin resistance impairs GI motility), comprehensive stool analysis with elastase (pancreatic exocrine insufficiency commonly co-exists with hypochlorhydria), and if Barrett’s esophagus concern, endoscopy with biopsies. Functional HCL testing: betaine HCL challenge or Heidelberg pH capsule for definitive hypochlorhydria diagnosis.
If you’ve been on PPIs for years without addressing the root cause of your reflux, functional medicine evaluation can identify whether you have hypochlorhydria, H. pylori, SIBO, hiatal hernia, or dietary drivers — and build a protocol to actually resolve the problem. Call The Private Practice at (810) 206-1402 to schedule a comprehensive GI evaluation.
Can GERD be cured without PPIs?
Yes — many cases of GERD, particularly functional GERD and non-erosive reflux disease (NERD), resolve completely with root cause treatment. Zalvan et al. (2017, JAMA Otolaryngology) showed Mediterranean plant-based diet produced equivalent symptom reduction to PPIs (omeprazole) with better 6-week outcomes, no side effects, and likely more durable improvement. H. pylori eradication resolves reflux in H. pylori-positive patients. SIBO treatment (rifaximin) resolves the fermentation-driven pressure mechanism. Melatonin 6 mg (Pereira 2006) matched omeprazole’s efficacy in a 351-patient RCT. Addressing the root cause — whether hypochlorhydria, infection, structural, or dietary — is both more effective and safer than indefinite acid suppression.
What are the long-term risks of PPIs?
Long-term PPI use (>3 months) carries significant risks: magnesium deficiency (FDA Black Box Warning — 2.6% develop clinically significant hypomagnesemia), vitamin B12 deficiency (65% higher risk — Lam 2013 AJGH), osteoporosis and hip fracture (44% higher risk — Gray 2010 JAMA), C. difficile infection (2.15× risk — Kwok 2012), small intestinal bacterial overgrowth development, rebound acid hypersecretion upon discontinuation (requiring gradual tapering with H2 blockers and antacids), and possible dementia risk (44% higher risk in a 73,679-patient cohort — Gomm 2016 JAMA Neurology). PPIs should be reserved for documented acid-related disease (erosive esophagitis, Barrett’s, H. pylori-associated ulcers) and used for the shortest effective period with nutritional monitoring.
Does low stomach acid cause acid reflux?
Counterintuitively, yes — hypochlorhydria (low stomach acid) is a primary cause of GERD in many patients. Adequate stomach acid (pH 1–3) is required to properly signal the lower esophageal sphincter (LES) to close after meals. When acid is insufficient, food ferments in the stomach, producing gas pressure that pushes contents upward through an incompetent LES. Additionally, hypochlorhydria impairs protein digestion (requires pepsin activation at low pH), impairs B12 absorption, reduces zinc and iron absorption, and allows bacterial overgrowth that further generates fermentation. Causes: H. pylori infection, aging (40% decline from age 30–80), zinc deficiency, chronic stress, PPI use, and autoimmune gastritis. Testing: betaine HCL challenge or Heidelberg pH capsule.
What is the best sleeping position for acid reflux?
Left lateral decubent position (sleeping on your left side) reduces nocturnal acid reflux exposure by 50–87% compared to the right lateral position (Khoury 1999, American Journal of Gastroenterology). The anatomy explains this: in the left lateral position, the gastric contents pool in the greater curvature fundus away from the gastroesophageal junction, while in the right lateral position, gastric contents pool near the cardia and LES. Elevating the head of the bed 6–8 inches (not just using extra pillows, which can increase intraabdominal pressure) reduces esophageal acid exposure during sleep. Supine position is worst for reflux — acid exposure in the esophagus is 2–3× higher supine vs. left lateral with head elevation.